The HRPP is offering several education classes for researchers, staff, and students in the upcoming months. Pre-registration is required.
Effective May 1, 2015, investigators will be required to submit a scientific protocol for new greater-than-minimal-risk studies. New study applications requiring a scientific protocol will be sent back to the investigator without CHR review if one is not attached. FAQs and resources for developing a scientific protocol are provided.
The HRPP is offering several iRIS classes for researchers, staff, and students in the upcoming months. Please register using the links provided, or visit our website to view the full training calendar. Pre-registration is required.
Generally speaking, you do not need to submit a modification to CHR solely to update your location. Instead, update the study location in the following materials the next time you submit a modification or at the time of continuing review.
The office of the Human Research Protection Program (HRPP) will be closed December 24th – January 2nd and re-opening on January 5th.
iRIS is extremely incompatible with Google Chrome and Internet Explorer version 10 and above. The CHR has had reports of serious issues resulting from use of these browsers, including irretrievable loss of data (even after saving) and the disappearance of key buttons in iRIS.
Internal (on-site) adverse events must now be submitted within 5-working days of UCSF PI awareness vs. 10 days previously.
The CHR office is implementing consistent minimum submission standards that will enable CHR staff to focus on well-prepared applications, resulting in faster reviews and approvals overall.

On April 4, 2014 we announced the start of a Lean process improvement project for Committee on Human Research’s (CHR) office to improve the application and approval process for new studies. Details about the project are available on the project website.

The CHR has published minor changes to the Study Application, Initial Review Submission Packet Form, the Modification Form, the Continuing Review Form, the Protocol Violation/Incident Reporting Form and the Adverse Event Reporting Form.